- NCIt
- C9466
Loading cancer entity…
Loading cancer entity…
Clinical trials
994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (85)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03403829 | Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage | unknown | Phase 3 | 360 | Fudan UniversityOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT02958111 | Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma(CAN) | unknown | Phase 3 | 406 | Sun Yat-sen UniversityOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03932266 | Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | unknown | Phase 2 | 73 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Apr 30, 2019 | clinicaltrials |
| NCT03601975 | Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 336 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 4, 2019 | clinicaltrials |
| NCT03557112 | By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC | unknown | Phase 2 | 180 | Guiyang Medical UniversityOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT03727594 | Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma | unknown | — | 50 | University Hospital of FerraraOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT03723343 | GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma | unknown | — | 146 | Guiyang Medical UniversityOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT03701451 | Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Wei JiangOTHER | 1 | Oct 10, 2018 | clinicaltrials |
| NCT03639467 | Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03666221 | Nimotuzumab for Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 67 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03657017 | PET/MR in Locally Advanced Nasopharyngeal Carcinoma | unknown | N/A | 150 | Zhejiang Cancer HospitalOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03647527 | Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy | unknown | — | 200 | Zhejiang Cancer HospitalOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03612219 | Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 240 | Wei JiangOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03578575 | To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma | unknown | Phase 2 | 120 | China Medical University HospitalOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 204 | Guiyang Medical UniversityOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03588403 | TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients | unknown | — | 110 | Zhejiang Cancer HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 266 | Guiyang Medical UniversityOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03568032 | Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma | unknown | — | 248 | Fudan UniversityOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT03529279 | CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy | unknown | Phase 3 | 1,324 | Sun Yat-sen UniversityOTHER | 0 | May 18, 2018 | clinicaltrials |
| NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 440 | Wei JiangOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03130270 | Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 29 | Guilin Medical University, ChinaOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC(NX-NPC) | unknown | Phase 3 | 632 | Sun Yat-sen UniversityOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | unknown | Phase 1 | 49 | National Cancer Centre, SingaporeOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01872962 | Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT03202173 | The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy | unknown | N/A | 31 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT03411954 | Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | unknown | Phase 2 | 328 | Yun-fei XiaOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03344068 | Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 408 | Sun Yat-sen UniversityOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03045484 | Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy | unknown | N/A | 70 | Sun Yat-sen UniversityOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT03290001 | The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients | unknown | — | 1,000 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 2 | 184 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03213587 | Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | unknown | Phase 2 | 51 | Zhejiang Cancer HospitalOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT03210389 | A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT03158324 | Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 | unknown | Phase 2 | 52 | National University Hospital, SingaporeOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC(De-ESCALaTE) | unknown | Phase 3 | 334 | University of WarwickOTHER | 3 | May 8, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT03087695 | Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma | unknown | — | 200 | Taichung Veterans General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT03068936 | IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | unknown | Phase 3 | 716 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Mar 3, 2017 | clinicaltrials |
| NCT03058432 | Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 122 | Zhejiang Cancer HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02878889 | A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. | unknown | Phase 2 | 53 | Zhejiang Cancer HospitalOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT03015727 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma(IRCNPC) | unknown | Phase 3 | 440 | Zhejiang Cancer HospitalOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT03006588 | EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients | unknown | Phase 2 / Phase 3 | 100 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT02871518 | Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 384 | Shanghai Proton and Heavy Ion CenterOTHER | 3 | Oct 27, 2016 | clinicaltrials |
| NCT02421640 | Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC(TIL) | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02907710 | Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 300 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02854410 | Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients | unknown | N/A | 30 | Capital Medical UniversityOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02786641 | Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 235 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02610556 | Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma | unknown | Phase 2 | 130 | Sun Yat-sen UniversityOTHER | 1 | May 26, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jul 8, 2019source: clinicaltrials